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Retrospective review of medical records and autopsy findings 
in patients dying of squamous cell cancer or adenocarcinoma of 
the uterine cervix was undertaken to evaluate for possible differences 
in biologic behavior between these tumor types. Twentyane patients 
with each tumor type were evaluated. Patients with adenocarcinoma 
were found to have a higher incidence of tumor involvement of 
the paraaortic lymph nodes (13/21 vs 6/20, P < O.OS), uterine 
corpus (17/17 vs 12/20, P < 0.05), and adrenal gland (7/21 vs 
O/21, P < 0.005). Presence of ascites (9/21 vs 2/21, P < 0.05) 
and hydrothorax (9/21 vs 3/21, P < 0.05) was also significantly 
more frequent in patients with adenocarcinoma. These findings 
suggest that this tumor may behave differently in regard to pattern 
of metastatic spread or response to therapy. The therapeutic 
implications of these findings deserve further study. Q 1989 Academic 
Press, Inc. 
The reported incidence of adenocarcinoma of the uterine 
cervix varies from 4 to 20% of all cervical malignancies, 
with most studies suggesting the true incidence to be 
near 5% [l-3]. Many studies suggest that the prognosis 
for patients with adenocarcinoma may be worse than 
that for patients with squamous cell cancer [4,5]. Proposed 
explanations have included differences in their patterns 
of growth and metastasis as well as sensitivity to radio- 
therapy. Although autopsy studies have helped to delineate 
the patterns of tumor spread and recurrence for squamous 
cell cancer [6] comparatively little autopsy information 
has been reported for cervical adenocarcinoma. To more 
completely evaluate for differences in tumor behavior 
we reviewed the medical records and autopsy reports of 
patients dying from adenocarcinoma of the uterine cervix 
and compared them with information obtained from pa- 
tients dying of cervical squamous cell cancer. 
’ To whom requests for reprints should be addressed. 
MATERIALS AND METHODS 
Study patients were identified by review of the Uni- 
versity of Michigan Medical Center (UMMC) tumor reg- 
istry from 1936 through 1985 for patients dying of cervical 
squamous cell or adenocarcinoma and who had autopsy 
performed at UMMC. A total of 165 patients were iden- 
tified, including 26 patients with adenocarcinoma and 139 
patients with squamous cell cancer. Medical records and 
autopsy reports were reviewed for information on tumor 
stage, type of therapy received, immediate cause of death, 
and anatomic location of tumor at autopsy. Histologic 
slides of tumors were reviewed and classified according 
to previously reported criteria [7]. Briefly, histologic fea- 
tures considered consistent with invasive adenocarcinoma 
included complex endocervical glandular architecture with 
areas of epithelial atypia and evidence of invasion through 
cervical stroma. Associated areas of in situ carcinoma 
were considered conclusive evidence of origin in endo- 
cervical glands or surface epithelium. Any case in which 
uncertainty existed as to the site of origin was excluded 
from analysis. Squamous cell cancer was diagnosed using 
standard criteria. Only patients with pure squamous cell 
cancer or adenocarcinoma were included in this report. 
All autopsies were performed at the University of 
Michigan Medical Center by resident pathologists under 
the supervision of staff physicians. A consistent autopsy 
protocol was utilized throughout the study period and 
the necropsy data were recorded on a standardized form. 
Areas examined for tumor were divided into four groups: 
lymph nodes, pelvis, abdomen, and miscellaneous. Nodal 
tissue examined included paraaortic, paratracheal, scalene, 
inguinal, axillary and retroperitoneal pelvic lymph nodes 
(RPLN). The RPLN group comprises nodal tissue iden- 
tified within the retroperitoneal tissue of the true pelvis 
and includes the external iliac, internal iliac, obturator, 
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and paracervical nodal tissue. The autopsy protocol at 
the University of Michigan does not provide for individual 
dissection of each of these nodal tissues. Pelvic sites 
included vulva, vagina, uterus, ovary, bladder, rectum, 
and ureter. The abdominal group included intraabdominal 
organs (adrenal glands, colon, gallbladder, kidneys, liver, 
omentum, pancreas, stomach, spleen, small bowel) as 
well as ascites and peritoneal studding. Ascites was defined 
as the presence of free intraperitoneal fluid of any amount. 
Peritoneal studding was considered present only when 
diffuse involvement of the abdominal and pelvic peri- 
toneum was noted. The miscellaneous group includes 
intrathoracic sites such as lung and pleura and hydrothorax 
(defined as free intrapleural fluid of any amount), as well 
as bone, skin, and central nervous system tissues. 
Comparisons between groups were made using a max- 
imum likelihood x2 test [8]. 
RESULTS 
Twenty-six patients with cervical adenocarcinoma were 
identified. Five patients were excluded, leaving 21 patients 
who ultimately composed this group. Three excluded 
patients were diagnosed and treated for cervical adeno- 
carcinoma but subsequently died of a second primary 
carcinoma and had no evidence of residual cervical cancer 
at autopsy. Second primary tumors in these patients in- 
cluded squamous cell carcinomas of the jaw, lung, and 
vagina. An additional patient was diagnosed with syn- 
chronous primary adenocarcinomas of the cervix and 
colon, and although metastatic lesions of both primaries 
were identified at autopsy they could not be clearly sep- 
arated histologically in all circumstances. The final patient 
excluded had previously undergone a supracervical hys- 
terectomy for endometrial adenocarcinoma. She subse- 
quently developed adenocarcinoma of the cervical stump, 
which appeared histologically to be of endocervical origin; 
however, the possibility of recurrent endometrial car- 
cinoma could not be excluded with certainty. 
A comparison group of 21 patients with squamous cell 
cancer was selected from the initial 139 by attempting 
to match as closely as possible tumor stage and date of 
diagnosis with patients in the adenocarcinoma group. 
The average year of diagnosis (mean 2 SD) was 1959 
+ 12 and 1966 ? 12 for patients with adenocarcinoma 
and squamous cell cancer, respectively. The incidence 
of nulliparity and average age at diagnosis were 20% 
(3/Z) and 49 years for patients with adenocarcinoma 
and 22% (4/18) and 50 years for patients with squamous 
cell disease. 
Stage of disease and subsequent therapy received are 
indicated in Tables 1 and 2. Two-thirds of patients in 
each group had either stage III or stage IV disease. Four 
patients (two from each group) received no therapy. Rea- 
TABLE 1 
FIG0 Stage of Cervical Cancer 
Histologic type 
Stage Squamous cell cancer Adenocarcinoma 
I 2 3 
II 5 4 
III 9 9 
IV 5 5 
Total 21 21 
sons for failure to treat included patient desire, underlying 
medical illness, or advanced disease. Radiation therapy 
was the most commonly used form of treatment and was 
utilized in 37 of 38 treated patients, including 14 patients 
with adenocarcinoma and 17 patients with squamous cell 
cancer who received radiation as the sole treatment mo- 
dality. External beam and brachytherapy were utilized 
in all but four patients who received external beam treat- 
ment alone. Combination radiation and surgical therapy 
was utilized in four patients with adenocarcinoma and 
two patients with squamous cell cancer. Chemotherapy 
was utilized in six patients after other treatment options 
had failed. This included two patients with squamous 
cell carcinoma and four patients with adenocarcinoma. 
Data regarding immediate cause of death are shown 
in Table 3. Obstructive renal disease and sepsis were the 
most frequent events resulting in death in both groups 
and accounted for 66% of deaths of known causes. 
Location of residual disease at the time of autopsy is 
shown in Table 4. RPLN involvement was noted in 61.2% 
of patients with squamous cell carcinoma and in 75% of 
patients with adenocarcinoma. Paraaortic and paratracheal 
nodal involvement was more frequently noted in patients 
with adenocarcinoma; however, this was statistically sig- 
nificant only at the paraaortic site (13/21 vs 6/20, P < 
0.05). Scalene nodes were involved in one patient in each 
group while inguinal or axillary nodal involvement was 
not noted in any patient. 
TABLE 2 
Therapy Received 
Squamous cell cancer Adenocarcinoma 
Therapy I” II III IV I II III IV 
RTXb 1 4 7 5 4 6 4 
SURG 1 
R&S 1 1 2 2 
None 1 I 1 1 
Total 2 5 9 5 3 4 9 5 
a Stage. 
b RTX, radiation; SURG, surgery; R&S, radiation and surgery. 
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TABLE 3 
Causes of Death 
Cause of death Squamous cell cancer Adenocarcinoma 
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Residual disease in the pelvis was a common finding 
in patients with both squamous cell cancer and adeno- 
carcinoma. Involvement of the uterine corpus was noted 
in all patients with adenocarcinoma who did not have 
their uterus removed as part of therapy, whereas disease 
in the uterus was noted in 12 of 20 patients with squamous 
cell carcinoma. This difference was statistically significant 
(17/17 vs 12/20, P < 0.05). Vaginal, ovarian, bladder, 
rectal, and ureteral involvement was found with ap- 
proximately equal frequency in each group. Vulvar in- 
volvement was not noted in either group. 
Liver was the most frequently involved intraabdominal 
organ and was noted to contain tumor in approximately 
one-third of all patients. Involvement of pancreas, spleen, 
stomach, gallbladder, and kidney was noted only rarely. 
There was no difference in frequency of involvement of 
these organs between groups. Adrenal gland involvement 
was noted in 7 of 21 patients with adenocarcinoma and 
in none of 21 patients with squamous cell (P < 0.005). 
Ascites was found more frequently in patients with ad- 
enocarcinoma (9/21 vs 2/21, P < 0.05). Clinically sig- 
nificant ascites (i.e., >500 ml) was noted in 45% of those 
patients with ascites, including four patients with ad- 
enocarcinoma and one patient with squamous cell cancer. 
Disseminated peritoneal involvement was noted twice as 
frequently in patients with adenocarcinoma (6/21 vs 3/21) 
but this difference was not statistically significant. Omental 
and small and large bowel involvement was noted in 
approximately one-fifth of patients and there was no dif- 
ference in involvement of these organs between groups. 
Tumor involvement of lung parenchyma was noted in 
7 of 21 patients with squamous cell cancer and 9 of 21 
patients with adenocarcinoma (P = n.s.). Involvement 
of the pleural cavity was noted less frequently in both 
groups, being found in 3 of 21 squamous cell carcinoma 
patients and 5 of 21 patients with adenocarcinoma (P = 
n.s.). Hydrothorax was noted significantly more frequently 
in patients with adenocarcinoma (9/21 vs 3/21, P < 0.05). 
The presence of hydrothorax was strongly associated 
with the simultaneous presence of ascites. All nine patients 
with hydrothorax in the adenocarcinoma group also had 
ascites, whereas ascites was found in only one of three 
patients with hydrothorax in the squamous cell cancer 
group. The volume of the hydrothorax exceeded 300 ml 
in three patients with adenocarcinoma and one patient 
with squamous cell cancer. 
DISCUSSION 
Retrospective study of necropsy data obtained in a 
consistent fashion offers a reliable method for determining 
the extent of malignant disease. Although the influence 
of confounding variables, such as differences in treatment 
modalities or host response, cannot be completely ex- 
eluded, the information obtained in this study suggests local hormonal environment that is favorable for the growth 
that important differences in biologic behavior exist be- of metastatic implants of adenocarcinoma. Metastases to 
tween squamous cell cancer and adenocarcinoma of the the adrenal gland never appeared to be clinically significant. 
uterine cervix. Ascites and hydrothorax were more common among 
Previous authors have suggested that cervical adeno- patients with adenocarcinoma and they usually occurred 
carcinoma may be relatively resistant to radiotherapy, simultaneously. The malignant characteristic of this fluid 
and improved survival with combination radiation and in the present study cannot be assured as cytologic studies 
surgical therapy over radiation therapy alone has been were not performed; however, contamination with ma- 
demonstrated in some reports. Berek et al. [4] found lignant cells seems highly likely as many of these patients 
residual tumor in 21% of surgical specimens from patients had gross tumor within the abdominal or pleural cavities. 
with stage I and II disease previously treated with ra- Of additional interest was the higher frequency of dis- 
diation, while Prempree et al. [9] noted a greater tendency seminated peritoneal involvement noted in patients with 
toward local and regional recurrences in patients treated adenocarcinoma, although this did not reach statistical 
with radiation therapy alone. In the present study residual significance. The tendency toward peritoneal spread and 
disease was found in the uterine corpus in all patients the formation of ascitic fluid suggests that intraabdominal 
with adenocarcinoma who did not undergo hysterectomy spread may be an important route of metastasis for cervical 
as part of therapy. Although four patients with residual adenocarcinoma. 
tumor in the uterus had stage II disease, the majority This report summarizes autopsy findings in patients 
had more advanced stage with large tumors, and poor dying of adenocarcinoma of the uterine cervix and com- 
control with radiation in these patients could be anticipated pares them to data obtained from patients with squamous 
based on the large initial tumor volume. At present the 
role of adjunctive surgical therapy is unclear, particularly 
cell cancer. Several differences were noted that suggest 
these tumors behave differently in regard to patterns of 
in patients with advanced disease. One cannot conclude 
from the data presented in this study that the addition 
spread and/or response to treatment. The therapeutic 
implications of these findings are unclear at present; how- 
of hysterectomy will improve survival. Residual disease ever, they may be more clearly defined with future study. 
following radiation therapy within the uterine corpus oc- 
curred significantly less frequently in patients with squa- 
mous cell cancer. 
It has been suggested that adenocarcinoma has a pro- 
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